Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Organic Process R&DOrganic Process R&D
Not Confirmed
Not Confirmed
10-12 March, 2025
European Pharma Congre...European Pharma Congress
Not Confirmed
Not Confirmed
10-11 March, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Organic Process R&DOrganic Process R&D
Industry Trade Show
Not Confirmed
10-12 March, 2025
European Pharma Congre...European Pharma Congress
Industry Trade Show
Not Confirmed
10-11 March, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/our-unmatched-efficiency-and-track-record-of-faster-dmf-filings-give-our-customers-a-critical-competitive-advantage
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/ai-drug-discovery-market-to-grow-30-cagr-to-reach-us-35-bn-by-2034-novo-lilly-bms-forge-deals
05 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/05/3037405/0/en/Silexion-Therapeutics-Reports-Groundbreaking-Positive-Initial-Data-from-Systemic-Administration-of-SIL204-in-Orthotopic-Pancreatic-Cancer-Models.html
03 Mar 2025
// BUSINESSWIRE
25 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/25/3032018/0/en/Silexion-Therapeutics-Announces-Completion-of-Initial-Study-in-Orthotopic-Pancreatic-Cancer-Models-Evaluating-Systemic-Administration-of-SIL-204.html
29 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/29/3017648/0/en/Silexion-Therapeutics-Announces-Exercise-of-Warrants-for-3-3-Million-Gross-Proceeds.html
29 Jan 2025
// BUSINESSWIRE
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/28/3016377/0/en/Silexion-Therapeutics-Reports-Strong-Tumor-Growth-Reduction-from-Systemic-Administration-of-SIL-204-in-Preclinical-Pancreatic-Cancer-Models.html
ABOUT THIS PAGE